Swathi Srivatsa

Swathi Srivatsa has extensive work experience in the pharmaceutical and consulting industries. Swathi worked at Fulcrum Therapeutics as the Senior Director of New Product Planning & FSHD Brand Lead, starting in January 2023. Prior to this, they held the position of Director of New Product Planning & Corporate Strategy at Fulcrum Therapeutics from August 2021 to December 2022. Before joining Fulcrum Therapeutics, Swathi worked at Putnam Associates, where they held various roles including Manager from April 2021 to July 2021, Senior Consultant from January 2020 to March 2021, Consultant from January 2019 to December 2019, and Life Sciences Consultant from June 2017 to December 2018.

Swathi Srivatsa completed their postdoctoral fellowship in Neural circuits and Behavior at Harvard Medical School from 2016 to 2017. Prior to that, they obtained a PhD in Neuroscience from The University of Göttingen between 2010 and 2014. Swathi also earned a Master of Science (MS) degree in Neuroscience from The University of Göttingen from 2008 to 2010. Their undergraduate education was at Mount Carmel College, Palace Rd, Bengaluru, where they received a Bachelor of Science (BS) degree in Chemistry, Zoology, and Microbiology from 2005 to 2008. Swathi attended National Public School from 1992 to 2005.